News
CDT
3.420
+5.88%
0.190
Weekly Report: what happened at CDT last week (0803-0807)?
Weekly Report · 5h ago
CDT Equity Expands Convertible Note and Equity Financing
TipRanks · 3d ago
Press Release: CDT Increases Stake in Sarborg following its Quantum Computing and Intellectual Property Expansion
Dow Jones · 08/03 12:30
Weekly Report: what happened at CDT last week (0727-0731)?
Weekly Report · 08/03 10:04
CDT Equity Expands Stake in Sarborg Via Warrants
TipRanks · 07/31 21:50
CDT Equity Enters Securities Purchase Agreement With Sarborg Investors On July 30, 2026; To Buy 4.76% Of Sarborg
Benzinga · 07/31 21:30
CDT Equity Issues Shares in Private Consulting Transaction
TipRanks · 07/29 21:11
Weekly Report: what happened at CDT last week (0720-0724)?
Weekly Report · 07/27 10:08
Weekly Report: what happened at CDT last week (0713-0717)?
Weekly Report · 07/20 10:05
CDT Highlights Sarborg's Patent Filing Extending Quantum-Enabled PRISM Platform to Sugarcane
Barchart · 07/20 07:30
Upcoming Stock Splits This Week (July 20 to July 24) – Stay Invested
TipRanks · 07/19 17:20
CDT Equity Inc trading halted, news pending
TipRanks · 07/17 23:55
CDT Equity Announces Reverse Stock Split on Nasdaq
TipRanks · 07/17 09:34
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 07/16 12:05
*CDT Equity: Reverse Split To Ensure Continued Compliance With the Nasdaq Bid-Price Rule >CDT
Dow Jones · 07/16 12:04
*CDT Equity Announces 1-For-10 Reverse Stk Split>CDT
Dow Jones · 07/16 12:01
CDT Equity Inc. Announces Reverse Stock Split
Barchart · 07/16 07:00
Conduit Pharmaceuticals Q1 EPS $(5.56) Up From $(3.67 thousand) YoY
Benzinga · 07/15 22:15
Weekly Report: what happened at CDT last week (0706-0710)?
Weekly Report · 07/13 10:06
CDT Equity Amends Convertible Note and Repayment Terms
TipRanks · 07/07 21:50
More
Webull provides a variety of real-time CDT stock news. You can receive the latest news about CDT Equity through multiple platforms. This information may help you make smarter investment decisions.
About CDT
CDT Equity Inc., formerly Conduit Pharmaceuticals, Inc. is a data-driven biotech development company focused on identifying, enhancing, and advancing high-potential therapeutic assets through scientific innovation and strategic partnerships. Through advanced co-crystallization and solidform technologies developed at its Cambridge facility, it is engaged in improving drug properties and has helped in extending the patent life of certain drugs by up to 20 years. Its pipeline includes candidates targeting inflammatory and autoimmune disorders, as well as idiopathic male infertility, dermatology and animal health. It applies proprietary algorithms utilizing AI-powered disease mapping to identify novel repurposing opportunities against a database of over 800 disease signatures. In addition, the Company has initiated pre-clinical in-vitro models to explore new indications, guided by AI-insights without human intervention.